According to AIM ImmunoTech 's latest financial reports the company's current earnings (TTM) are -$20.78 M. In 2022 the company made an earning of -$19.45 M a decrease over its 2021 earnings that were of -$19.13 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$20.78 M | 6.84% |
2022 | -$19.45 M | 1.66% |
2021 | -$19.13 M | 32.66% |
2020 | -$14.42 M | 51.18% |
2019 | -$9.54 M | -2.81% |
2018 | -$9.82 M | 18.82% |
2017 | -$8.26 M | 10.09% |
2016 | -$7.51 M | -50.74% |
2015 | -$15.23 M | -12.72% |
2014 | -$17.45 M | 7.55% |
2013 | -$16.23 M | -6.51% |
2012 | -$17.36 M | 21.22% |
2011 | -$14.32 M | -7.56% |
2010 | -$15.49 M | 16.76% |
2009 | -$13.27 M | 3.54% |
2008 | -$12.82 M | -33.58% |
2007 | -$19.29 M | 3.18% |
2006 | -$18.7 M | 89.3% |
2005 | -$9.88 M | -9.31% |
2004 | -$10.89 M | 50.17% |
2003 | -$7.26 M | 9.55% |
2002 | -$6.62 M | -24.79% |
2001 | -$8.81 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | 787.22% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | -8.79% | ๐บ๐ธ USA |